269 related articles for article (PubMed ID: 25252941)
21. Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation.
Fukuchi Y; Ito M; Shibata F; Kitamura T; Nakajima H
Stem Cells; 2008 Dec; 26(12):3172-81. PubMed ID: 18787208
[TBL] [Abstract][Full Text] [Related]
22. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.
Iwasaki H; Somoza C; Shigematsu H; Duprez EA; Iwasaki-Arai J; Mizuno S; Arinobu Y; Geary K; Zhang P; Dayaram T; Fenyus ML; Elf S; Chan S; Kastner P; Huettner CS; Murray R; Tenen DG; Akashi K
Blood; 2005 Sep; 106(5):1590-600. PubMed ID: 15914556
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of mouse mu opioid receptor gene by PU.1.
Hwang CK; Kim CS; Choi HS; McKercher SR; Loh HH
J Biol Chem; 2004 May; 279(19):19764-74. PubMed ID: 14998994
[TBL] [Abstract][Full Text] [Related]
24. Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.
Le Coz C; Nguyen DN; Su C; Nolan BE; Albrecht AV; Xhani S; Sun D; Demaree B; Pillarisetti P; Khanna C; Wright F; Chen PA; Yoon S; Stiegler AL; Maurer K; Garifallou JP; Rymaszewski A; Kroft SH; Olson TS; Seif AE; Wertheim G; Grant SFA; Vo LT; Puck JM; Sullivan KE; Routes JM; Zakharova V; Shcherbina A; Mukhina A; Rudy NL; Hurst ACE; Atkinson TP; Boggon TJ; Hakonarson H; Abate AR; Hajjar J; Nicholas SK; Lupski JR; Verbsky J; Chinn IK; Gonzalez MV; Wells AD; Marson A; Poon GMK; Romberg N
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33951726
[TBL] [Abstract][Full Text] [Related]
25. The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis.
Hoogenkamp M; Krysinska H; Ingram R; Huang G; Barlow R; Clarke D; Ebralidze A; Zhang P; Tagoh H; Cockerill PN; Tenen DG; Bonifer C
Mol Cell Biol; 2007 Nov; 27(21):7425-38. PubMed ID: 17785440
[TBL] [Abstract][Full Text] [Related]
26. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
Marecki S; Riendeau CJ; Liang MD; Fenton MJ
J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
[TBL] [Abstract][Full Text] [Related]
27. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
28. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
29. Conversion of adult endothelium to immunocompetent haematopoietic stem cells.
Lis R; Karrasch CC; Poulos MG; Kunar B; Redmond D; Duran JGB; Badwe CR; Schachterle W; Ginsberg M; Xiang J; Tabrizi AR; Shido K; Rosenwaks Z; Elemento O; Speck NA; Butler JM; Scandura JM; Rafii S
Nature; 2017 May; 545(7655):439-445. PubMed ID: 28514438
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis.
Lichtinger M; Ingram R; Hannah R; Müller D; Clarke D; Assi SA; Lie-A-Ling M; Noailles L; Vijayabaskar MS; Wu M; Tenen DG; Westhead DR; Kouskoff V; Lacaud G; Göttgens B; Bonifer C
EMBO J; 2012 Nov; 31(22):4318-33. PubMed ID: 23064151
[TBL] [Abstract][Full Text] [Related]
31. PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells.
De Smedt J; van Os EA; Talon I; Ghosh S; Toprakhisar B; Furtado Madeiro Da Costa R; Zaunz S; Vazquez MA; Boon R; Baatsen P; Smout A; Verhulst S; van Grunsven LA; Verfaillie CM
Cell Death Dis; 2021 Jan; 12(1):84. PubMed ID: 33446637
[TBL] [Abstract][Full Text] [Related]
32. Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence.
Org T; Duan D; Ferrari R; Montel-Hagen A; Van Handel B; Kerényi MA; Sasidharan R; Rubbi L; Fujiwara Y; Pellegrini M; Orkin SH; Kurdistani SK; Mikkola HK
EMBO J; 2015 Mar; 34(6):759-77. PubMed ID: 25564442
[TBL] [Abstract][Full Text] [Related]
33. A critical role for PU.1 in homing and long-term engraftment by hematopoietic stem cells in the bone marrow.
Fisher RC; Lovelock JD; Scott EW
Blood; 1999 Aug; 94(4):1283-90. PubMed ID: 10438716
[TBL] [Abstract][Full Text] [Related]
34. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
Nerlov C; Graf T
Genes Dev; 1998 Aug; 12(15):2403-12. PubMed ID: 9694804
[TBL] [Abstract][Full Text] [Related]
35. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks.
Chopin M; Seillet C; Chevrier S; Wu L; Wang H; Morse HC; Belz GT; Nutt SL
J Exp Med; 2013 Dec; 210(13):2967-80. PubMed ID: 24249112
[TBL] [Abstract][Full Text] [Related]
36. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
Stanulovic VS; Cauchy P; Assi SA; Hoogenkamp M
Nucleic Acids Res; 2017 Sep; 45(17):9874-9888. PubMed ID: 28973433
[TBL] [Abstract][Full Text] [Related]
37. The analysis of novel distal Cebpa enhancers and silencers using a transcriptional model reveals the complex regulatory logic of hematopoietic lineage specification.
Bertolino E; Reinitz J; Manu
Dev Biol; 2016 May; 413(1):128-44. PubMed ID: 26945717
[TBL] [Abstract][Full Text] [Related]
38. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene.
Krysinska H; Hoogenkamp M; Ingram R; Wilson N; Tagoh H; Laslo P; Singh H; Bonifer C
Mol Cell Biol; 2007 Feb; 27(3):878-87. PubMed ID: 17116688
[TBL] [Abstract][Full Text] [Related]
39. Synthetic TAL effectors for targeted enhancement of transgene expression in plants.
Liu W; Rudis MR; Peng Y; Mazarei M; Millwood RJ; Yang JP; Xu W; Chesnut JD; Stewart CN
Plant Biotechnol J; 2014 May; 12(4):436-46. PubMed ID: 24373379
[TBL] [Abstract][Full Text] [Related]
40. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.
Zhang P; Zhang X; Iwama A; Yu C; Smith KA; Mueller BU; Narravula S; Torbett BE; Orkin SH; Tenen DG
Blood; 2000 Oct; 96(8):2641-8. PubMed ID: 11023493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
